According to a TechSci Research report titled “Canada Biosimilar Contract Manufacturing Market – By Region, Competition, Forecast and Opportunities, 2028,” the biosimilar c… Read More

According to a report by TechSci Research, the global biosimilar contract manufacturing market is expected to grow at an impressive rate from 2024 to 2028. This growth is driven by the incre… Read More

Service providers have introduced the latest upgrades in their portfolio in order to achieve a competitive edge. These upgrades primarily target upstream bottlenecks related to the developme… Read More

Alcami Corp., a CDMO, has completed the Phase III expansion of its cGMP biostorage facility in Amherst, NH, creating a total of 160,000 ft² of ambient cGMP biostorage capacity with 21,0… Read More

Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), and The Vistria Group today announced that they have completed the acquisition of Alcami Corporation (&ldquo… Read More

The global microbial identification market is projected to grow at a CAGR of 6.6% during the forecast period 2022 – 2031. The microbial identification market is expected to reach US… Read More

Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), announced the addition of a 3,800 ft² Non-GMP Formulation Development Laboratory (FDL). T… Read More

The Outsourced Clinical Trials & Formulation Market is slated to grow at a gracious rate of 6.7%, reaching  US$ 19.6 Bn by the year 2027. With a value-oriented approach be… Read More

Alcami, a global pharmaceutical contract development and manufacturing organization (CDMO), announced today that its Board of Directors has appointed Patrick D. Walsh as Chairman and Chief E… Read More

The Packaging CDMO market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study. This market report also allows you to… Read More

Vancouver, British Columbia--(Newsfile Corp. - March 8, 2021) - Crystal Bridge Enterprises Inc. (TSXV: CRYS.P) (the "Company") is pleased to provide an update regarding its Qualifying Transa… Read More

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of Alcami’s Germantown, Wisconsin facility in the US. The ne… Read More

The factors such as the high cost of instruments and complex regulatory framework for the approval of new microbial diagnostic tests may restrain the market’s growth to a certain exten… Read More

The global Microbial Identification market is segmented on the basis of product & service, method, application, end user and region. The market growth is primarily driven by th… Read More

The report “Microbial Identification Market by Product & Service (Instruments, Consumables, Identification Services), Method (Phenotypic, Proteomics-based, Genotypic), Ap… Read More